These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38842925)

  • 1. Defining and Risk-Stratifying Immunosuppression (the DESTINIES Study): Protocol for an Electronic Delphi Study.
    Leston M; Ordóñez-Mena J; Joy M; de Lusignan S; Hobbs R; McInnes I; Lee L
    JMIR Res Protoc; 2024 Jun; 13():e56271. PubMed ID: 38842925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disparities in COVID-19 mortality amongst the immunosuppressed: A systematic review and meta-analysis for enhanced disease surveillance.
    Leston M; Elson W; Ordóñez-Mena JM; Kar D; Whitaker H; Joy M; Roberts N; Hobbs FDR; de Lusignan S
    J Infect; 2024 Mar; 88(3):106110. PubMed ID: 38302061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
    Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
    Trials; 2014 Jun; 15():247. PubMed ID: 24962012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developing a Framework for Pandemic COVID-19 Vaccine Allocation: a Modified Delphi Consensus Study in Korea.
    Choi MJ; Choi WS; Seong H; Choi JY; Kim JH; Kim YJ; Cho EY; Kim DH; Park H; Lee H; Kim NJ; Song JY; Cheong HJ; Kim SI; Peck KR
    J Korean Med Sci; 2021 Jun; 36(23):e166. PubMed ID: 34128597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining Advance Care Planning for Adults: A Consensus Definition From a Multidisciplinary Delphi Panel.
    Sudore RL; Lum HD; You JJ; Hanson LC; Meier DE; Pantilat SZ; Matlock DD; Rietjens JAC; Korfage IJ; Ritchie CS; Kutner JS; Teno JM; Thomas J; McMahan RD; Heyland DK
    J Pain Symptom Manage; 2017 May; 53(5):821-832.e1. PubMed ID: 28062339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outpatient treatment with concomitant vaccine-boosted convalescent plasma for patients with immunosuppression and COVID-19.
    Ripoll JG; Tulledge-Scheitel SM; Stephenson AA; Ford S; Pike ML; Gorman EK; Hanson SN; Juskewitch JE; Miller AJ; Zaremba S; Ovrom EA; Razonable RR; Ganesh R; Hurt RT; Fischer EN; Derr AN; Eberle MR; Larsen JJ; Carney CM; Theel ES; Parikh SA; Kay NE; Joyner MJ; Senefeld JW
    mBio; 2024 May; 15(5):e0040024. PubMed ID: 38602414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Core outcome measurement set for research and clinical practice in post-COVID-19 condition (long COVID) in children and young people: an international Delphi consensus study "PC-COS Children".
    Seylanova N; Chernyavskaya A; Degtyareva N; Mursalova A; Ajam A; Xiao L; Aktulaeva K; Roshchin P; Bobkova P; Aiyegbusi OL; Anbu AT; Apfelbacher C; Asadi-Pooya AA; Ashkenazi-Hoffnung L; Brackel C; Buonsenso D; de Groote W; Diaz JV; Dona D; Dunn Galvin A; Genuneit J; Goss H; Hughes SE; Jones CJ; Kuppalli K; Malone LA; McFarland S; Needham DM; Nekliudov N; Nicholson TR; Oliveira CR; Schiess N; Segal TY; Sigfrid L; Thorne C; Vijverberg S; Warner JO; Were WM; Williamson PR; Munblit D;
    Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38359962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Protocol to Develop Extended COVID-19 Surveillance and Trial Platforms.
    de Lusignan S; Jones N; Dorward J; Byford R; Liyanage H; Briggs J; Ferreira F; Akinyemi O; Amirthalingam G; Bates C; Lopez Bernal J; Dabrera G; Eavis A; Elliot AJ; Feher M; Krajenbrink E; Hoang U; Howsam G; Leach J; Okusi C; Nicholson B; Nieri P; Sherlock J; Smith G; Thomas M; Thomas N; Tripathy M; Victor W; Williams J; Wood I; Zambon M; Parry J; O'Hanlon S; Joy M; Butler C; Marshall M; Hobbs FDR
    JMIR Public Health Surveill; 2020 Jul; 6(3):e19773. PubMed ID: 32484782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus building on definitions and types of child maltreatment to improve recording and surveillance in Europe: protocol for a multi-sectoral, European, electronic Delphi study.
    Nurmatov U; Cowley LE; Rodrigues LB; Naughton A; Debelle G; Alfandari R; Lamela D; Otterman G; Jud A; Ntinapogias A; Laajasalo T; Soldino V; Stancheva V; Caenazzo L; Vaughan R; Christian CW; Drabarek K; Kemp AM; Hurt L;
    BMJ Open; 2023 Dec; 13(12):e076517. PubMed ID: 38086601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishing an updated consensus on the conceptual and operational definitions of Making Every Contact Count (MECC) across experts within research and practice: an international Delphi Study.
    Nichol B; Kemp E; Wilson R; Rodrigues AM; Hesselgreaves H; Robson C; Haighton C
    Public Health; 2024 May; 230():29-37. PubMed ID: 38484623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
    Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
    Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for Welcoming Back Nursing Home Visitors During the COVID-19 Pandemic: Results of a Delphi Panel.
    Bergman C; Stall NM; Haimowitz D; Aronson L; Lynn J; Steinberg K; Wasserman M
    J Am Med Dir Assoc; 2020 Dec; 21(12):1759-1766. PubMed ID: 33256956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultural Adaptation of the Actionable Health App Evaluation in Japan: Protocol for a Web-Based Modified Delphi Expert Consensus Study.
    Yokomitsu K; Takashina HN; Takebayashi Y; Muranaka S
    JMIR Res Protoc; 2023 Nov; 12():e44469. PubMed ID: 37921839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for an international Delphi exercise to identify a core set of domains and domain items for national atopic eczema registries.
    Gerbens LA; Boyce AE; Wall D; Barbarot S; de Booij RJ; Deleuran M; Middelkamp-Hup MA; Roberts A; Vestergaard C; Weidinger S; Apfelbacher CJ; Irvine AD; Schmitt J; Williamson PR; Spuls PI; Flohr C
    Trials; 2017 Feb; 18(1):87. PubMed ID: 28241851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of immunosuppressants in the era of coronavirus disease-2019.
    Manansala M; Baughman R; Novak R; Judson M; Sweiss N
    Curr Opin Pulm Med; 2021 May; 27(3):176-183. PubMed ID: 33779588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.